Table 3 General characteristics of the total study population
From: Atherosclerosis is associated with plasma Aβ levels in non-hypertension patients
Variable | Non-Hypertension group (n = 148) | Hypertension group (n = 196) | p |
|---|---|---|---|
Age (y, mean ± SD) | 56.85 ± 10.37 | 60.10 ± 8.94 | 0.002 |
Female (n, %) | 44 (29.7%) | 116 (59.2%) | <0.0001 |
Diabetes mellitus (n, %) | 31(20.9%) | 65(33.2%) | 0.012 |
Cardiovascular disease (n, %) | 10(23.3%) | 33(76.7%) | 0.005 |
Stroke (n, %) | 35(34.0%) | 68(66.0%) | 0.027 |
Smoking (n, %) | 85(57.4%) | 63(42.6%) | <0.0001 |
FBG (mmol/L, Median) | 5.47(5.05,6.40) | 5.61(5.18,6.53) | 0.904 |
Lack of Exercise (n, %) | 44(44.4%) | 55(55.6%) | 0.735 |
Drinking (n, %) | 35(60.3%) | 23(39.7%) | 0.003 |
dyslipidemia (n, %) | 101(40.1%) | 151(59.9%) | 0.068 |
Carotid atherosclerosis (n, %) | 99(39.4%) | 152(60.6%) | 0.028 |
BMI (kg/m2, mean ± SD) | 26.66 ± 2.90 | 27.43 ± 3.16 | 0.021 |
TC (mmol/L, mean ± SD) | 5.35 ± 1.12 | 5.39 ± 1.19 | 0.760 |
TG (mmol/L, Median) | 1.87(1.30,2.58) | 1.82(1.37,2.45) | 0.924 |
HDL-c (mmol/L, mean ± SD) | 1.33 ± 0.34 | 1.36 ± 0.31 | 0.419 |
LDL-c (mmol/L, mean ± SD) | 1.36 ± 0.31 | 3.63 ± 1.04 | 0.842 |
Aβ1−40 (pg/ml, mean ± SD ) | 52.44 ± 9.32 | 52.89 ± 9.15 | 0.654 |
Aβ1−42 (pg/ml, mean ± SD) | 40.81 ± 6.52 | 40.61 ± 6.26 | 0.774 |
Aβ1−40 / Aβ1−42 (mean ± SD) | 1.32 ± 0.34 | 1.33 ± 0.33 | 0.692 |